Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Werle

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
AJR. American Journal of Roentgenology|July 25, 2007
Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomasRonald J Zagoria, Michael A Traver, David M Werle, et al.
Urology|April 16, 2011
Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinomaRonald J Zagoria, Joseph A Pettus, Morgan Rogers, et al.
Journal of Endourology|September 8, 2010
Percutaneous radiofrequency ablation does not affect glomerular filtration rateJoseph A Pettus, David M Werle, Weston Saunders, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
AJR. American Journal of Roentgenology|July 25, 2007
Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomasRonald J Zagoria, Michael A Traver, David M Werle, et al.
Urology|April 16, 2011
Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinomaRonald J Zagoria, Joseph A Pettus, Morgan Rogers, et al.
Journal of Endourology|September 8, 2010
Percutaneous radiofrequency ablation does not affect glomerular filtration rateJoseph A Pettus, David M Werle, Weston Saunders, et al.
Pageof 1